Möchten Sie immer auf dem neuesten Stand bleiben?

EnGeneIC Honored with 2026 Breakthrough in glioblastoma Biotech Award at Northwell Foundation Lenox Hill Neurosurgery Brain Cancer Gala in New York

Belleville, Illinois, June 04, 2026 (GLOBE NEWSWIRE) -- Allsup, a leading provider of Social Security Disability Insurance (SSDI) representation, return to work and veterans disability appeals...

Ona Therapeutics closes oversubscribed $86.6M Series B financing to advance first-in-class ADCs into clinical development for treatment-resistant cancers

Vancouver, B.C., June 02, 2026 (GLOBE NEWSWIRE) -- VGH & UBC Hospital Foundation today announced that its Greater Than Cancer campaign raised more than $39 million to advance cancer diagnostics,...

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 01, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a...

Eli Lilly's (NYSE:LLY) strong Phase 3 results for Retevmo places the oncology community in the spotlight

OCALA, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant milestone in its pancreatic cancer development program,...

SOUTH SAN FRANCISCO, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen...

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Can

The report tracks key market indicators, sustainability trends, investment flows and innovation patterns shaping the global life sciences landscape.